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Background: Mean platelet volume (MPV) is a reflection of platelet size, which has been shown to correlate with
platelet function and activation. The aim of this study was to evaluate whether MPV could be used for the
diagnostic tool of community-acquired pneumonia (CAP) and for making the decision for hospitalization.
Methods: The computerized records of children aged 1 to 18 years who were diagnosed with CAP based on WHO
criteria were evaluated. A standard protocol was followed, and patients with severe CAP were hospitalized. CAP
patients were divided into two groups based on disease severity. The control group consisted of age and gender
matched healthy children during the study period. Values for hemoglobin, white blood cell count (WBC), platelet
count, MPV and C-reactive protein (CRP) obtained on first presentation were recorded for each patient.
Results: A total of 196 patients were diagnosed with CAP during the study period, 108 (55.1%) of which had severe
disease, which required hospitalization (Group 1a), while the remaining 88 (44.9%) were followed-up as outpatients
(Group 1b). The control group consisted of 100 healthy children (Group 2). Patients with CAP had lower MPV values
than their healthy counterparts (7.1±0.68 vs. 8.31±1.2 fL; p<0.001). MPV value was significantly higher in hospitalized
CAP patients compared to outpatients (7.32±0.71 vs. 6.83±0.5 fL; p=0.012). ROC curve analysis suggested that MPV
level cut-off point for making a diagnosis of CAP was 8.1 fL, with a sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) of 91%, 51%, 80.8% and 70.5%, respectively.
Conclusions: Our findings suggest that MPV may be a useful predictor for diagnosed CAP but low specificity and
NPV rates may lead to the false-negative diagnosis.
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Community-acquired pneumonia (CAP) is a serious and
frequent cause of hospital admission in early childhood [1]
In developing countries, the incidence of childhood hospi-
talizations due to CAP is estimated to be 8.7% of all cases
of CAP [2], whereas the hospitalization rates for children
under the age of 5 years in the UK and USA are 2.9/1000
[3] and 6.6/1000 [4], respectively. The clinical spectrum of
CAP in children ranges from mild disease, which can be
managed on an outpatient basis, to a severe life-threatening
condition requiring prolonged intensive care [1].* Correspondence: dredakaradag@gmail.com
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distribution, and reproduction in any mediumMany biochemical markers have been investigated in as-
sociation with clinical outcome in patients with CAP, in-
cluding several cytokines such as tumour necrosis
factor-α and interleukin 6 (IL-6), C-reactive protein (CRP),
procalcitonin, and D-dimer. The role of cytokines as im-
portant mediators of lung defence against infections and
inflammation is well documented. Cytokines may have ei-
ther pro- or anti-inflammatory effects depending on a
multiple of interacting microbiologic, environmental, and
genetic factors that are believed to influence host response
to respiratory infections [5-8].
There is a growing body of clinical evidence suggesting
that platelets play an important role in the inflammatory re-
sponse. Multiple inflammatory factors such as chemokines,
cytokines and coagulation factors are secreted by platelets,Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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let volume (MPV) is a reflection of platelet size, which has
been shown to correlate with platelet function and activa-
tion. A higher MPV value is indicative of increased platelet
activity and thus more intense inflammation [9]. Changes
in MPV have been studied in several chronic inflammatory
diseases [10-14], however, to the best of our knowledge,
such changes have not been previously studied in associ-
ation with CAP. The aim of our study was to investigate
whether MPV values are affected by the inflammatory re-
sponse in childhood CAP.Materials and methods
Study design
This study was approved by the local ethics committee in
accordance with the Helsinki Declaration. Informed con-
sent was obtained from the parent or legal guardian of each
participant. This retrospective study was conducted in
Ihsan Dogramaci Children’s Hospital of the Faculty of
Medicine at Hacettepe University, which serves as a referral
tertiary care center for all Anatolia. The medical records of
children between 1–18 years of age who were diagnosed
with CAP at the Department of Pediatric Infectious
Diseases between January 2010 and June 2012 were system-
atically reviewed. Excluded criteria were presence of under-
lying chronic disease, history of previous hospitalization,
any blood diseases or anemia. In all patients, a diagnosis of
pneumonia was made based on the case definition pro-
posed by the World Health Organization (WHO); any child
presenting with cough or breathing difficulties was consid-
ered eligible if they had tachypnea (>40/min, age 12–59
months; >30/min, age ≥60 months) or in drawing without
wheeze, as well as having an abnormal chest radiograph
(consolidation or perihilar infiltrates) [15]. Patients with se-
vere CAP, as defined by WHO [16] and British Thoracic
Society [17] criteria, were hospitalized. The control group
consisted of healthy age and gender-matched children who
attended the “Well-child” clinic for routine check-up in the
same period.
Information regarding demographics, medical history,
clinical characteristics and laboratory results were
retrieved from computerized hospital medical records.
Complete blood counts were performed for all patients on
presentation using a commercially available analyzer
(Sysmex XT 2000i, Roche Diagnostics GmnH, Mannheim,
Germany). Hemoglobin level, white blood cell count
(WBC), platelet count, and MPV values were recorded for
each patient. The reference range for MPV was between
7.0 and 11 fL. All CAP patients also had baseline CRP
levels available. Chest radiographs of the study population,
which were retrieved from the hospital’s database, were
re-evaluated by a designated pediatric radiologist for the
presence of signs supporting a diagnosis of CAP.Statistical analyses
Statistical analyses were performed using the Statistical
Package for Social Sciences version 17.0 (SPSS for Windows
17.0, Inc., Chicago, IL, USA). Categorical variables were
provided as numbers and percentages, whereas numerical
variables were given as mean ± standard deviation. Gender
comparisons between groups were made using the Chi-
square test. Initial comparisons of laboratory parameters
between the three groups were made using either the
Welch analysis of variance (ANOVA) test or the Kruskal
Wallis test, depending on normality of distribution,
followed by two-way comparisons using either the t-test for
independent samples or the Mann–Whitney test, respect-
ively. The cut-off value for MPV that best distinguishes be-
tween healthy controls and CAP patients were determined
using ROC analysis, for which sensitivity and specificity
values were calculated. A p-value of less than 0.05 was con-
sidered indicative of statistical significance.
Results
A total of 196 patients were diagnosed with CAP in the de-
partment of Pediatric Infectious Diseases, 108 (55.1%) of
which required hospitalization (Group 1a), while the
remaining 88 (44.9%) were followed-up on an outpatient
basis (Group 1b) with oral antibiotics. The control group
(Group 2) consisted of 100 children without an underlying
chronic disorder who underwent blood workup during rou-
tine check-up. The mean age of all participants was 6.8±4.3
years (Group 1a, 6.9±3.9 years; Group 1b, 6.6±4.8 years,
Group 2, 6.9±4.3 years), with an overall gender distribution
of 52% males and 48% females. The difference between the
three groups with regards to mean age (p=0.93) and gender
distribution (p=0.22) was statistically insignificant.
Patients with CAP had a significantly lower mean MPV
value compared to healthy controls (7.1±0.68 vs. 8.31±1.2
fL; p<0.001). ROC curve analysis suggested that MPV level
cut-off point for making a diagnosis of CAP was 8.1 fL,
with a sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) of 91%, 51%,
80.8% and 70.5%, respectively (Area under curve: 0.796).
MPV value was significantly higher in hospitalized CAP pa-
tients compared to outpatients (7.32±0.71 vs. 6.83±0.5 fL;
p=0.012). MPV values of groups are depicted in Figure 1.
WBC levels were significantly higher in CAP patients
who were hospitalized (p<0.001) or followed-up as out-
patients (p<0.001) than healthy controls. CRP levels were
significantly higher in CAP patients who were hospital-
ized compared to those who were followed-up as outpa-
tients (p<0.001). A summary of laboratory results of the
study population is provided in Table 1.
Discussion
Platelet volume, which is determined at the level of pro-
genitor cells (i.e. the megakaryocyte), is correlated with
Figure 1 Comparison of MPV values in Group 1a (n=108),
Group 1b (n=88) and Group 2 (n=100).
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an indicator of platelet function has been investigated in
association with several inflammatory disorders such as
cystic fibrosis [10], ulcerative colitis [11], rheumatoid arth-
ritis [12], familial Mediterranean fever (FMF) [13], neo-
natal respiratory distress syndrome [14] and infections
such as upper urinary tract infections [19] and sepsis
[20,21]. In previous studies, it has been suggested that cy-
tokines such as IL-3 and IL-6 may influence megakaryo-
cyte ploidy leading to the production of larger and more
reactive platelets [22,23]. IL-6, which plays a central role
in the inflammatory process of sepsis and CAP, is also be-
lieved to affect MPV. The relationship between MPV and
sepsis has also been evaluated in a number of studies
[20,24]. Becchi et al. [20] reported on higher mean MPV
values in patients who survived sepsis compared to those
who did not survive. In a study on children with CAP, out
of 15 different cytokines investigated, a significant correl-
ation with disease severity could only be observed with
IL-6 levels [25]. These studies may help explain the lower
MPV values we observed in CAP patients compared to
healthy controls. Logistic regression analysis revealed an
MPV value of less than 8.1 on presentation to have a sen-
sitivity of 91%, a specificity of 51%, a PPV of 80.8% and aTable 1 Comparison of laboratory parameters of study popul
Parameter Group 1a (hospitalized) (n=108) Group 1b
Hb (/gL) 121±16
WBC (109/L) 13100 [2500–50500] 9800
Platelet count (109/L) 34610±151365 33
CRP (mg/dL) 3.98 [0.2-42]
MPV (fL) 7.32±0.71
aGroup 1a versus Group 1b, bGroup 1a versus Group 2, cGroup 1b versus Group 2.
Variables showed Mean±SD or median [min-max]; Hb, hemoglobin; WBC, white blo
NS, not significant.NPV of 70.5% for CAP diagnosis. The low specificity and
NPV rates may lead to the false-negative diagnosis.
To the best of our knowledge, this is the first study in
which the role of MPV as a diagnostic and prognostic fac-
tor for CAP has been evaluated. In our study patients with
more severe disease that required hospitalization were
found to have significantly higher MPV values compared
to patients who were followed-up on an outpatient basis
(p=0.012). The lower MPV values observed in patients
followed-up on an outpatient basis are an interesting find-
ing that is not interpretable based on current knowledge.
It may be hypothesized that the bone marrow response to
the infection is inadequate in CAP cases followed as out-
patients, and that an increase in platelet size only occurs
as a result of damage or consumption of peripheral circu-
lating platelets due hyper stimulation. Considering that
patients who require hospitalization tend to be brought to
the hospital at a later stage of the disease, it may be postu-
lated that MPV decreases during the earlier stages of CAP,
which is followed by a significant increase in MPV as a
result of bone marrow activation.
Pneumonia can generally be accepted as an infectious in-
flammatory process of the lungs. There are some studies
that varied MPV levels in certain inflammatory conditions.
Studies conducted in children, in regard of control groups
MPV decreased significantly in acute exacerbation period
of cystic fibrosis [10], Kawasaki disease with coronary artery
lesion [26], acute attack period of FMF on colchicine treat-
ment [13]. In regard of control groups MPV increased sig-
nificantly during acute attack and attack-free period of
pediatric FMF [27], in adult FMF [28], adult active tubercu-
losis which decreased significantly with anti-tuberculous
therapy [29]. Tuncel et al. [30] in a recent study demon-
strated that MPV values in asthmatic children both during
an asthmatic attack and during the asymptomatic period
had no statistically significant difference compared to the
healthy control group. And they found that no statistically
significant difference between mean MPV values in asthma
exacerbation and asymptomatic period. An increased MPV
levels (unrelated with platelet count and the type of cul-
tured microorganisms) was found in 13 of 25 patients with
culture proven septicemia but none of control groupation
(outpatient) (n=88) Group 2 (control) (n=100) p-value
124±14 128±11 NSa,c 0.05b
[2500–24000] 7900 [4100–12700] 0.019a <0.001b,c
5110±128930 321805±79030 NSa,b,c
0.8 [0.1-6.2] - <0.001a
6.83±0.5 8.31±1.2 0.012a <0.001b,c
od cell count; CRP, C-reactive protein; MPV, mean platelet volume;
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After one week of treatment MPV was normalized [24].
Robbins et al. [31] made a comment about the MPV and
infection relationship. They concluded that at least two pat-
terns of platelet size changes could be possible in response
to infection: an early rise in MPV in severe infection such
as septicemia (may be associated with thrombocytopenia)
and a later decrease in MPV with sustained or chronic or
persisted bacterial infection (may be associated with
thrombocytosis). However, we believe that future prospect-
ive studies may help elucidate whether MPV could be used
in the follow-up of CAP patients, particularly for the evalu-
ation of response of treatment.
Some studies reported that CRP was associated with dis-
ease severity and mortality in hospitalized patients with
CAP [5,32]. This is not our main purpose but in our study
by comparing CRP and WBC levels of hospitalized CAP
patients and those followed-up on an outpatient basis, we
managed to demonstrate a statistically significant correl-
ation between CRP and WBC levels and disease severity.
Our study has some limitations because of its retro-
spective nature. Therefore we could not calculate the time
interval between the onset of symptoms and blood sam-
pling. If we achieve this data, we could explain more
clearly the difference between MPV values in hospitalized
patients and outpatients.
In conclusion, MPV is a simple parameter that is pro-
vided by most commercially available automated hema-
tology analyzers, with no associated extra cost or effort.
Our findings suggest that MPV may be a useful predictor
for diagnosed CAP but not in disease severity. However cli-
nicians should be aware of the low specificity (51%) and
NPV (70.5%) rates that may lead to the false-negative diag-
nosis. Further prospective studies on a larger patient popu-
lation are required to establish the exact role of MPV in
patients with CAP, either as an indicator of disease severity
or for the evaluation of response to treatment.
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